 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| The Effect of Denosumab on Bone Mass in Super Elderly Patients |
| Chaiho Jeong, Jeonghoon Ha |
|
jbm. 2020;27(2):119-124. Published online May 31, 2020 DOI: https://doi.org/10.11005/jbm.2020.27.2.119 |
|
The Effect of Denosumab on Bone Mass in Super Elderly Patients Journal of Bone Metabolism. 2020;27(2):119  Impact of denosumab on bone mass in cancer patients Clinical Pharmacology: Advances and Applications. 2013;117 Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys Journal of Bone and Mineral Research. 2015;30(4):657-669 Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study Nephrology Dialysis Transplantation. 2021;36(10):1900-1907 Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial Yearbook of Endocrinology. 2009;2009:210-212 Denosumab Reactions Weekly. 2014;1489(1):15-15 Effect of Zoledronic Acid and Denosumab in Patients With Low Back Pain and Modic Change: A Proof-of-Principle Trial Journal of Bone and Mineral Research. 2018;33(5):773-782 Effect of switching from bisphosphonates to denosumab on bone metabolism in aromatase inhibitor-treated breast cancer patients Osteoporosis and Sarcopenia. 2017;3(3):S13 Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass Yearbook of Endocrinology. 2011;2011:182-184 Denosumab dominates in elderly osteoporosis patients PharmacoEconomics & Outcomes News. 2012;666(1):8-8 |
